Double Delight For Novartis At The CHMP

Backing For MS Drug Mayzent And Isturisa For Cushing's

 
• By Kevin Grogan
  
Hurdles
Mayzent Over Final Hurdle Before European approval • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip